The GRAIL Galleri is a multi-cancer early detection test. It tests for more than 50 types of cancer.
Galleri has a low false positive rate through a single blood draw. Their scientists, engineers, and clinicians believe this new test can help reduce deaths and decrease healthcare costs by detecting cancers earlier.
They use the power of next-generation sequencing, population-scale clinical studies, and computer science. Read more on GRAIL's approach here.